Abstract | BACKGROUND: CONCLUSIONS: Although Gal-3 showed prognostic value, the effect of canrenone on clinical outcomes was unaffected by baseline concentrations of biomarkers of fibrosis or cardiac stress.
|
Authors | Francesco Clemenza, Serge Masson, Pier Giulio Conaldi, Daniele Di Carlo, Alessandro Boccanelli, Gian Francesco Mureddu, Lucio Gonzini, Donata Lucci, Aldo P Maggioni, Andrea Di Lenarda, Enrico B Nicolis, Massimo Vanasia, Roberto Latini, AREA IN-CHF Investigators |
Journal | Circulation journal : official journal of the Japanese Circulation Society
(Circ J)
Vol. 81
Issue 10
Pg. 1543-1546
(Sep 25 2017)
ISSN: 1347-4820 [Electronic] Japan |
PMID | 28855452
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Biomarkers
- Blood Proteins
- Galectin 3
- Galectins
- LGALS3 protein, human
- Mineralocorticoid Receptor Antagonists
- Canrenone
|
Topics |
- Aged
- Biomarkers
(blood)
- Blood Proteins
- Canrenone
(therapeutic use)
- Female
- Fibrosis
- Galectin 3
(blood)
- Galectins
- Heart Failure
(diagnosis, drug therapy)
- Humans
- Male
- Middle Aged
- Mineralocorticoid Receptor Antagonists
(therapeutic use)
- Prognosis
- Treatment Outcome
|